Merck names new CEO
Frazier will succeed Richard Clark, who has served as Merck’s CEO since 2005 and will continue as chairman of the board. Merck said that Frazier has served as
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly and Company’s (Lilly) olomorasib as a potential treatment for adults with advanced pancreatic cancer who have already received at least one prior systemic therapy.
StayinFront claims that EdgeRx delivers fully featured on-demand CRM and integrated analytics capabilities, while offering the flexibility to access the system online or offline. StayinFront EdgeRx includes everything